RHB-104
RHB-104-02
Phase 2 small_molecule completed
Quick answer
RHB-104 for Relapsing Remitting Multiple Sclerosis is a Phase 2 program (small_molecule) at RedHill Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- RedHill Biopharma
- Indication
- Relapsing Remitting Multiple Sclerosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed